ImmunityBio (IBRX) Insider Trading & Ownership → This 1 Biotech Stock has been shocking the markets (From Huge Alerts) (Ad) Free IBRX Stock Alerts $8.05 +0.13 (+1.64%) (As of 11:57 AM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ImmunityBio (NASDAQ:IBRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage83.40%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$268,516.25Number OfInsiders Selling(Last 12 Months)0 Get IBRX Insider Trade Alerts Want to know when executives and insiders are buying or selling ImmunityBio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IBRX Insider Buying and Selling by Quarter Ad InvestorPlace1970’s computer coder Issues Shocking AI WarningLouis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology… Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans.Click here to watch his new video ASAP ImmunityBio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/5/2023Michael D BlaszykDirectorBuy71,915$2.75$197,766.25 6/2/2023John Owen BrennanDirectorBuy25,000$2.83$70,750.00 (Data available from 1/1/2013 forward) IBRX Insider Trading Activity - Frequently Asked Questions Who is on ImmunityBio's Insider Roster? The list of insiders at ImmunityBio includes Barry J Simon, Cheryl Cohen, John Owen Brennan, Michael D Blaszyk, and Richard Adcock. Learn more on insiders at IBRX. What percentage of ImmunityBio stock is owned by insiders? 83.40% of ImmunityBio stock is owned by insiders. Learn more on IBRX's insider holdings. Which ImmunityBio insiders have been buying company stock? The following insiders have purchased IBRX shares in the last 24 months: John Owen Brennan ($70,750.00), and Michael D Blaszyk ($197,766.25). How much insider buying is happening at ImmunityBio? Insiders have purchased a total of 96,915 IBRX shares in the last 24 months for a total of $268,516.25 bought. More Insider Trading Tools from MarketBeat Related Companies: HALO Insider Trades CRSP Insider Trades RVMD Insider Trades KRYS Insider Trades PCVX Insider Trades IMVT Insider Trades EXEL Insider Trades SWTX Insider Trades IOVA Insider Trades IMCR Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:IBRX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford ClubObama’s Forever Term [exposed]Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunityBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
